Bio-Techne Corporation — Operating Income by Fiscal Year

18 fiscal years, as filed with the SEC; every row links its evidence fact.

Cite as: FACTANKER, https://factanker.com/entity/d1d07354-3c7d-493b-b31a-cd22bea7fbb7/serie/operating-income

Fiscal yearOperating IncomePeriodEvidence
FY 2026$251.9M2025-07-01 – 2026-06-30evidence 0001104659-26-100322
FY 2025$102.3M2024-07-01 – 2025-06-30evidence 0001558370-25-011716
FY 2024$206.7M2023-07-01 – 2024-06-30evidence 0001558370-24-012430
FY 2023$298.9M2022-07-01 – 2023-06-30evidence 0001558370-23-015226
FY 2022$296.6M2021-07-01 – 2022-06-30evidence 0001558370-22-013935
FY 2021$237.3M2020-07-01 – 2021-06-30evidence 0001437749-21-020980
FY 2020$157.4M2019-07-01 – 2020-06-30evidence 0001437749-20-018754
FY 2019$146.7M2018-07-01 – 2019-06-30evidence 0001437749-19-017565
FY 2018$136.2M2017-07-01 – 2018-06-30evidence 0001437749-18-016190
FY 2017$120.6M2016-07-01 – 2017-06-30evidence 0001437749-17-015711
FY 2016$150.6M2015-07-01 – 2016-06-30evidence 0001437749-16-038182
FY 2015$147.0M2014-07-01 – 2015-06-30evidence 0001437749-16-038182
FY 2014$159.8M2013-07-01 – 2014-06-30evidence 0001193125-14-327566
FY 2013$158.5k2012-07-01 – 2013-06-30evidence 0001437749-15-016645
FY 2012$166.2M2011-07-01 – 2012-06-30evidence 0001193125-12-373084
FY 2011$163.1M2010-07-01 – 2011-06-30evidence 0001193125-11-235045
FY 2010$156.3M2009-07-01 – 2010-06-30evidence 0001193125-11-235045
FY 2009$150.8M2008-07-01 – 2009-06-30evidence 0001193125-11-235045
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

Bio-Techne Corporation — all facts · Revenue · Net Income